Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001213900-20-002768
Filing Date
2020-02-06
Accepted
2020-02-06 15:16:43
Documents
1
Group Members
DANIEL HOPPDH-CAPITAL GMBH & CO. KGDIETMAR HOPPDR. MATHIAS HOTHUMOH BETEILIGUNGEN GMBH & CO. KGOLIVER HOPPPROF. DR. CHRISTOF HETTICHPROF. DR. FRIEDRICH VON BOHLEN UND HALBACH

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO.2 TO SCHEDULE 13G sc13g0220a2dievini_acimmune.htm SC 13G/A 297123
  Complete submission text file 0001213900-20-002768.txt   298918
Mailing Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000
Business Address EPFL INNOVATION PARK, BUILDING B 1015 LAUSANNE V8 00000 41 21 345 91 21
AC Immune SA (Subject) CIK: 0001651625 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89853 | Film No.: 20582459
SIC: 2834 Pharmaceutical Preparations

Mailing Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190
Business Address JOHANN-JAKOB-ASTOR STR. 57 WALLDORF 2M 69190 62278608462
dievini Hopp BioTech holding GmbH & Co KG (Filed by) CIK: 0001696029 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: SC 13G/A